(S)-5'-chloro-5-(cyclobutylmethyl)-2',3',4,5-tetrahydro-2H-spiro[benzo[b][1,4]oxazepine-3,1'-indene]-7-carboxylic acid

ID: ALA4449176

Chembl Id: CHEMBL4449176

PubChem CID: 138320064

Max Phase: Preclinical

Molecular Formula: C23H24ClNO3

Molecular Weight: 397.90

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)c1ccc2c(c1)N(CC1CCC1)C[C@@]1(CCc3cc(Cl)ccc31)CO2

Standard InChI:  InChI=1S/C23H24ClNO3/c24-18-5-6-19-16(10-18)8-9-23(19)13-25(12-15-2-1-3-15)20-11-17(22(26)27)4-7-21(20)28-14-23/h4-7,10-11,15H,1-3,8-9,12-14H2,(H,26,27)/t23-/m0/s1

Standard InChI Key:  YLXRDIJLTBHLLJ-QHCPKHFHSA-N

Alternative Forms

  1. Parent:

    ALA4449176

    ---

Associated Targets(Human)

MCL1 Tchem Induced myeloid leukemia cell differentiation protein Mcl-1 (3820 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 397.90Molecular Weight (Monoisotopic): 397.1445AlogP: 4.92#Rotatable Bonds: 3
Polar Surface Area: 49.77Molecular Species: ACIDHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 5.15CX Basic pKa: 3.97CX LogP: 5.09CX LogD: 3.12
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.80Np Likeness Score: -0.21

References

1. Denis C, Sopková-de Oliveira Santos J, Bureau R, Voisin-Chiret AS..  (2020)  Hot-Spots of Mcl-1 Protein.,  63  (3): [PMID:31580668] [10.1021/acs.jmedchem.9b00983]
2. Li K..  (2021)  Interdiction at a protein-protein interface: MCL-1 inhibitors for oncology.,  32  [PMID:33253879] [10.1016/j.bmcl.2020.127717]
3. Hiesinger K, Dar'in D, Proschak E, Krasavin M..  (2021)  Spirocyclic Scaffolds in Medicinal Chemistry.,  64  (1.0): [PMID:33381970] [10.1021/acs.jmedchem.0c01473]
4. Wan Y, Fang G, Chen H, Deng X, Tang Z..  (2021)  Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation.,  226  [PMID:34530384] [10.1016/j.ejmech.2021.113837]

Source